US Edition
Published • loading... • Updated
CAB-LA: Prevention jab that never had its moment, what it leaves behind as LEN arrives
Summary by Sunday World
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CAB-LA: Prevention jab that never had its moment, what it leaves behind as LEN arrives
In 2026, as South Africa prepares to introduce lenacapavir, another HIV-prevention injection is fading from view: long-acting cabotegravir, known as CAB-LA in short. Both lenacapavir and CAB-LA consist of antiretroviral medication that prevents HIV-negative people from getting infected with HIV through sex, but the former is taken once every six months and the latter once every two months. LEN roll-out in pipeline ARVs are the same type of medic…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
